Attenuation of oxygen free radical formation and tissue injury during experimental inflammation by P-selectin blockade

被引:31
作者
Delano, FA
Forrest, MJ
SchmidSchonbein, GW
机构
[1] UNIV CALIF SAN DIEGO,DEPT BIOENGN,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,INST BIOMED ENGN,LA JOLLA,CA 92093
[3] CYTEL CORP,LA JOLLA,CA
来源
MICROCIRCULATION-LONDON | 1997年 / 4卷 / 03期
关键词
rat mesentery; endothelium; leukocyte rolling; superoxide; nitroblue tetrazolium reduction; propidium iodide; platelet activating factor;
D O I
10.3109/10739689709146799
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Neutrophilic leukocyte rolling on postcapillary endothelium requires membrane interaction between SLe(x)-containing ligands on neutrophils and P-selectin on endothelial cells. The current sequence of studies was performed to explore the hypothesis that the leukocyte-endothelial rolling interaction not only precedes leukocyte migration but also is accompanied by oxygen free radical production and interstitial cell death in the rat mesentery. Methods: The ratio of leukocyte rolling velocity on the endothelium of postcapillary venules and centerline red cell velocity was determined after topical application of platelet activating factor (PAF; 10(-8) mol/L). Superoxide formation was determined by an in situ nitroblue tetrazolium reduction to dark blue formazan crystals in the in situ mesentery preparation, and cell death was detected by nuclear staining with propidium iodide. Results: Leukocyte rolling and subsequent adhesion was inhibited with a monoclonal antibody against P-selectin, PB1.3. Superoxide formation, as well as parenchymal cell death, was significantly enhanced in the mesentery after stimulation with platelet activating factor, and both could be significantly attenuated by reduction of die rolling leukocyte-endothelial interaction with PB1.3. Conclusions: These results provide direct evidence that the interaction of leukocytes and endothelium followed by migration of leukocytes into the interstitium is accompanied by entranced oxidative stress and parenchymal cell death. Early interruption of the interaction provides significant protection even in the presence of a proinflammatory stimulus.
引用
收藏
页码:349 / 357
页数:9
相关论文
共 29 条
  • [1] [Anonymous], PHYSL PATHOPHYSIOLOG
  • [2] CIRCULATING NEUTROPHIL KINETICS DURING TOLERANCE IN HEMORRHAGIC-SHOCK USING BACTERIAL LIPOPOLYSACCHARIDE
    BARROSOARANDA, J
    CHAVEZCHAVEZ, RH
    MATHISON, JC
    SUEMATSU, M
    SCHMIDSCHONBEIN, GW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (02): : H415 - H421
  • [3] Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock
    BarrosoAranda, J
    Zweifach, BW
    Mathison, JC
    SchmidSchonbein, GW
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 : S23 - S29
  • [4] TRANSFORMATION OF NEUTROPHILS AS INDICATOR OF IRREVERSIBILITY IN HEMORRHAGIC-SHOCK
    BARROSOARANDA, J
    SCHMIDSCHONBEIN, GW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (03): : H846 - H852
  • [5] PAF-ACETHER (PLATELET-ACTIVATING FACTOR) INCREASES MICROVASCULAR PERMEABILITY AND AFFECTS ENDOTHELIUM-GRANULOCYTE INTERACTION IN MICROVASCULAR BEDS
    BJORK, J
    LINDBOM, L
    GERDIN, B
    SMEDEGARD, G
    ARFORS, KE
    BENVENISTE, J
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 119 (03): : 305 - 308
  • [6] NEUTROPHIL-MEDIATED MICROVASCULAR DYSFUNCTION IN POSTISCHEMIC CANINE SKELETAL-MUSCLE - ROLE OF GRANULOCYTE-ADHERENCE
    CARDEN, DL
    SMITH, JK
    KORTHUIS, RJ
    [J]. CIRCULATION RESEARCH, 1990, 66 (05) : 1436 - 1444
  • [7] PULMONARY MICROVASCULAR INJURY AFTER INTESTINAL ISCHEMIA-REPERFUSION - ROLE OF P-SELECTIN
    CARDEN, DL
    YOUNG, JA
    GRANGER, DN
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1993, 75 (06) : 2529 - 2534
  • [8] PLATELET-LEUKOCYTE INTERACTION - ACTIVATION OF RABBIT PLATELETS BY FMLP-STIMULATED NEUTROPHILS
    COEFFIER, E
    JOSEPH, D
    PREVOST, MC
    VARGAFTIG, BB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (02) : 393 - 406
  • [9] DORE M, 1993, BLOOD, V82, P1308
  • [10] DURAN WN, 1990, J LIPID MEDIATOR, V2, pS215